Prof. Dr. Xiaona Lin, Hangzhou Women’s Hospital, China.
Prof. Dr. Xiaona Lin 🧬 is a Chief Physician, PhD, and Assistant Director at Hangzhou Maternity and Child Healthcare Hospital. A doctoral supervisor at Zhejiang University, she specializes in Obstetrics and Gynecology 🩺. Her research focuses on reproductive surgery, stem cell therapy, and intrauterine adhesion treatment. With over 25 high-impact publications 📚 and multiple national awards 🏆, she is a recognized leader in reproductive medicine and a driving force in advancing women’s health globally. 🌍
Profile
SCOPUS ID
🎓 Early Academic Pursuits
Prof. Dr. Xiaona Lin began her academic journey at Zhejiang Medical University, earning her Bachelor’s degree in Clinical Medicine. She advanced to complete a Master’s in Medicine at Zhejiang University School of Medicine and later a Ph.D. in Obstetrics and Gynecology at the same institution. Her academic development was enriched through advanced training in the USA, UK, and Hong Kong, gaining international exposure in reproductive health and minimally invasive gynecology. 📚🌍
💼 Professional Endeavors
Dr. Lin dedicated nearly three decades to Sir Run Run Shaw Hospital, Zhejiang University, serving in both Obstetrics and Gynecology and the Reproductive Medicine Center. In 2025, she transitioned to Hangzhou Maternity and Child Healthcare Hospital as Assistant Director. Throughout her clinical career, she has held leadership roles in national medical associations, contributing to innovation in gynecological diagnostics and reproductive health management. 🏥🩺
🔬 Contributions and Research Focus On Gynecology
Dr. Lin’s research has advanced the understanding of female infertility and intrauterine adhesions. Her key focus includes stem cell-based regenerative therapies, recurrent implantation failure, and placental function disorders. She has led numerous national and provincial projects, including studies on Lgr5+ organoids, chondroitin-chitosan scaffolds, and miRNA-modulated endometrial fibrosis. Her investigations have established her as a pioneer in translational reproductive research. 🧬🧫
🌍 Impact and Influence
A respected academic and clinician, Dr. Lin holds prominent positions across 12+ national and regional medical committees, including the Chinese Association for Improving Birth Outcomes, Chinese Sexology Association, and Zhejiang Medical Association. Her influence extends into policy, education, and clinical innovation, shaping the future of maternal and reproductive healthcare in China. 🇨🇳💡
🧠 Research Skills
Dr. Lin demonstrates exceptional skills in molecular diagnostics, minimally invasive surgery, and biomaterial applications for gynecological therapy. Her expertise spans regenerative medicine, organ-on-chip models, clinical trial coordination, and biostatistical analysis. She integrates multidisciplinary strategies for solving complex reproductive challenges. 🧪⚙️
🏅 Awards and Honors
Dr. Lin’s innovations have been recognized with multiple prestigious awards, including:
-
🥈 Zhejiang Science and Technology Award (2009)
-
🥉 Zhejiang Medical and Health Science and Technology Award (2016)
-
🥇 First Prizes in 2017 and 2021 for contributions to ART success and birth outcomes improvement
🏛️ Legacy and Future Contributions
Prof. Dr. Lin’s legacy lies in her ability to bridge clinical excellence and academic innovation. She continues to mentor future physicians and scientists as a Doctoral Supervisor at Zhejiang University. Her future endeavors are expected to drive breakthroughs in stem cell therapy, non-invasive fertility treatments, and integrative reproductive health approaches for global maternal well-being. 🌱👩🔬
Publications Top Notes
📄 Clinical characteristics and laparoscopic management experience of primary ovarian leiomyoma.
Journal: Scientific Reports 🧪
Year: 2025
🧬 Hexokinase 2-driven aerobic glycolysis modulates YAP1 in placental trophoblast development
Journal: Biochimica et Biophysica Acta – Molecular Basis of Disease 🧫
Year: 2025
📊 Development and validation of a predictive nomogram for the pregnancy rate after tubal anastomosis
Journal: Laparoscopic Endoscopic and Robotic Surgery 🔍
Year: 2025
🩺 Conception and Concern: A Review of Breast Cancer Risk in Assisted Reproductive Technology
Type: Review Article 🔄
Year: 2025
🧵 Numerical model of jet formation during melt electrowriting for fabrication of precise structures
Journal: Additive Manufacturing 🧵
Year: 2024
🤖 Multimodal learning system integrating electronic medical records and hysteroscopic images for reproductive outcome prediction and risk stratification of endometrial injury: a multicenter diagnostic study
Journal: International Journal of Surgery (London, England) 🏥
Year: 2024
Citations: 4
🧫 Engraftment of self-renewing endometrial epithelial organoids promotes endometrial regeneration by differentiating into functional glands in rats
Journal: Frontiers in Bioengineering and Biotechnology 🧬
Year: 2024